X- linked recessive
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus, CTCAE 3.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of macular pigmentation
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the eye
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Nystagmus, CTCAE 5.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Severe myopia
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
Four potential pathogenic variations in the NYX gene were found in four families with high myopia with or without CSNB1.
|
25802485 |
2015 |
Myopia
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
Myopia is a complex eye disorder.The X-linked form of complete congenital stationary night blindness (CSNB1A) is usually associated with moderate to high myopia, and is caused by mutations in the NYX gene.
|
23406521 |
2013 |
Severe myopia
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
The coding regions of the NYX gene were sequenced for 204 Chinese males with high myopia (-8.00 dioptres or worse for both eyes).
|
23406521 |
2013 |
Myopia
|
0.130 |
Biomarker
|
disease |
BEFREE |
The observations suggest that NYX may have independent effects on myopia and night blindness.
|
17392683 |
2007 |
Myopia
|
0.130 |
GeneticVariation
|
disease |
LHGDN |
Mutations in NYX of individuals with high myopia, but without night blindness.
|
17392683 |
2007 |
Severe myopia
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
Two unrelated male individuals with high myopia but without night blindness were found to have novel Cys48Trp and Arg191Gln mutations in NYX.
|
17392683 |
2007 |
Myopia
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
The importance of associated myopia with NYX mutations is discussed.
|
16670814 |
2006 |
Myopia
|
0.130 |
Biomarker
|
disease |
HPO |
|
|
|
Severe myopia
|
0.130 |
Biomarker
|
disease |
HPO |
|
|
|
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Night blindness, congenital stationary, type 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cone-rod synaptic disorder, congenital nonprogressive
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Disorder of eye
|
0.310 |
GeneticVariation
|
group |
BEFREE |
Myopia is a complex eye disorder.The X-linked form of complete congenital stationary night blindness (CSNB1A) is usually associated with moderate to high myopia, and is caused by mutations in the NYX gene.
|
23406521 |
2013 |
Disorder of eye
|
0.310 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Disorder of eye
|
0.310 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
X-Linked Csnb
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
A common NYX mutation in Flemish patients with X linked CSNB.
|
18617546 |
2009 |
X-Linked Csnb
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Here we have studied 22 families with 'complete' X-linked CSNB (CSNB1; MIM 310500; ref.
|
11062471 |
2000 |
X-Linked Csnb
|
0.340 |
Biomarker
|
disease |
BEFREE |
Genetic and clinical analyses of this set of 32 families with X-linked CSNB, together with the family studies reported in the literature, strongly suggest that two loci, one for complete (CSNB1) and one for incomplete (CSNB2) X-linked CSNB, can account for all reported mapping information.
|
9529339 |
1998 |
X-Linked Csnb
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
The apparent clinical heterogeneity in X-linked CSNB reflects the recently described genetic heterogeneity in which the locus for complete CSNB (CSNB1) was mapped to Xp11.4, and the locus for incomplete CSNB (CSNB2) was refined within Xp11.23 (ref.5).
|
9662400 |
1998 |